Loading...
Antiangiogenic Therapy for Diabetic Nephropathy
Angiogenesis has been shown to be a potential therapeutic target for early stages of diabetic nephropathy in a number of animal experiments. Vascular endothelial growth factor (VEGF) is the main mediator for abnormal angiogenesis in diabetic glomeruli. Although beneficial effects of anti-VEGF antibo...
Na minha lista:
| Udgivet i: | Biomed Res Int |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5556994/ https://ncbi.nlm.nih.gov/pubmed/28835895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5724069 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|